From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches.
Bifulco
M
M
Laezza
C
C
Malfitano
A M
AM
D002186:Cannabinoids / Q000627:therapeutic use*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use
D002186:Cannabinoids; D011619:Psychotropic Drugs